Formulation development and risk assessment for fixed dose combination contains tolbutamide & voglibose for treating type II diabetes mellotus.

By:

Material type: Text

TextDescription: iv,99Dissertation note: 2023 SELVAKUMAR K.

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Collection	Call number	Status	Date due	Barcode
ACP-Thesis & Dissertations	Acharya & BM Reddy College of Pharmacy Dept. of Quality Assurance	Acharya & BM Reddy College of Pharmacy	ACP-Quality Assurance	615.190 068 5 ANU (Browse shelf(Opens below))	Available		ACP-T674

	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	No cover image available No cover image available	Next
	615.190 068 5 Risk management of Titrimetric analytical methods by quality Risk management.	615.190 068 5 ANU Formulation development and risk assessment for fixed dose combination contains tolbutamide & voglibose for treating type II diabetes mellotus.	615.190 068 5 CHA Chiral interconversion study of cetirizine enantiomers in formulation containing chiral excipients.	615.190 068 5 GIR Comparative study of In-Silico interactions between EGFR and the standrd drugs used in the teratment of Non-small cell lug cancer.	615.190 068 5 NAG Formulation development and evaluation of griseofulvin transdermal patches by using a quality by design framework.	Next

2023 SELVAKUMAR K.

There are no comments on this title.

to post a comment.